Form 8-K - Current report:
SEC Accession No. 0001193125-23-188876
Filing Date
2023-07-18
Accepted
2023-07-18 16:25:28
Documents
14
Period of Report
2023-07-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d838523d8k.htm   iXBRL 8-K 43617
2 EX-99.1 d838523dex991.htm EX-99.1 17160
3 EX-99.2 d838523dex992.htm EX-99.2 10701
  Complete submission text file 0001193125-23-188876.txt   216508

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amrn-20230718.xsd EX-101.SCH 2518
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20230718_lab.xml EX-101.LAB 19333
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20230718_pre.xml EX-101.PRE 12081
8 EXTRACTED XBRL INSTANCE DOCUMENT d838523d8k_htm.xml XML 3882
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 231094517
SIC: 2834 Pharmaceutical Preparations